Edition:
United States

ContraVir Pharmaceuticals Inc (CTRV.OQ)

CTRV.OQ on NASDAQ Stock Exchange Capital Market

0.98USD
12:52pm EDT
Change (% chg)

$-0.06 (-5.66%)
Prev Close
$1.04
Open
$1.05
Day's High
$1.05
Day's Low
$0.95
Volume
26,148
Avg. Vol
22,071
52-wk High
$6.56
52-wk Low
$0.95

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Mar '18 0.00 -0.266
Sep 0.00 -0.075
FY 2017 Dec '17 0.00 -0.139
Sep '17 0.00 -0.603
Sep '17 0.00 -0.075
Dec 0.00 -0.600
FY 2016 Jun '16 0.00 -1.300
Mar '16 0.00 -1.148
Dec 0.00 -0.910
Sep 0.00 -1.739
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Sep-18 1 0.00 0.00 0.00 --
Quarter Ending Dec-18 1 0.00 0.00 0.00 --
Year Ending Dec-18 1 0.00 0.00 0.00 --
Year Ending Dec-19 1 0.00 0.00 0.00 --
Earnings (per share)
Quarter Ending Sep-18 2 -0.38 -0.38 -0.39 --
Quarter Ending Dec-18 2 -0.37 -0.34 -0.39 --
Year Ending Dec-18 2 -1.40 -1.37 -1.43 --
Year Ending Dec-19 2 -1.03 -0.66 -1.40 --
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 85.36 32.76
P/E High - Last 5 Yrs. -- 298.43 45.44
P/E Low - Last 5 Yrs. -- 91.46 24.26
Beta 1.54 0.93 0.89
Price to Sales (TTM) -- 112.59 5.73
Price to Book (MRQ) 5.85 15.55 5.47
Price to Tangible Book (MRQ) 12.10 14.65 7.05
Price to Cash Flow (TTM) -- 72.62 23.29
% Owned Institutions 9.99 14.53 2.21

Dividends

  Company industry sector
Dividend Yield -- 0.35 1.51
Dividend Yield - 5 Year Avg -- 0.27 1.52
Dividend 5 Year Growth Rate -- 1.70 5.22
Payout Ratio(TTM) -- 16.36 43.78

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 408.16 8.01
Sales (TTM) vs TTM 1 Yr. Ago -- 79.91 5.64
Sales - 5 Yr. Growth Rate -- 32.07 10.18
EPS (MRQ) vs Qtr. 1 Yr. Ago 117.49 29.00 20.60
EPS (TTM) vs TTM 1 Yr. Ago 53.86 -- --
EPS - 5 Yr. Growth Rate -- 39.51 10.66
Capital Spending - 5 Yr. Growth Rate -- 39.99 15.33

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.92 2.22
Current Ratio (MRQ) 4.48 5.49 3.03
LT Debt to Equity (MRQ) 0.00 34.93 12.51
Total Debt to Equity (MRQ) 0.00 36.74 16.84
Interest Coverage (TTM) -- -101.19 32.64

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 39.30 54.37
Gross Margin - 5 Yr. Avg. -- 50.70 52.17
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -587.40 10.81
Operating Margin (TTM) -- -734.14 4.57
Operating Margin - 5 Yr. Avg. -- -609.01 6.23
Pre-Tax Margin (TTM) -- -708.28 5.43
Pre-Tax Margin - 5 Yr. Avg. -- -612.53 6.67
Net Profit Margin (TTM) -- -709.68 1.72
Net Profit Margin - 5 Yr. Avg. -- -615.55 2.94
Effective Tax Rate (TTM) -- 23.24 23.11
Effective Tax Rate - 5 Yr. Avg. -- 18.56 23.98

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 23,033,779 860,399,112
Net Income/Employee (TTM) -- 3,118,930 101,210,045
Receivable Turnover (TTM) -- 20.76 5.87
Inventory Turnover (TTM) -- 2.48 3.41
Asset Turnover (TTM) 0.00 0.41 0.94

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -94.57 0.26 11.14
Return on Assets - 5 Yr. Avg. -- 3.71 12.40
Return on Investment (TTM) -126.93 2.21 14.61
Return on Investment - 5 Yr. Avg. -- 2.88 16.14
Return on Equity (TTM) -- 3.85 16.34
Return on Equity - 5 Yr. Avg. -- 3.83 17.40
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % 59.33 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for ContraVir Pharmaceuticals Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 6.87%
# of Holders: 37
Total Shares Held: 734,038
3 Mo. Net Change: -6,250
# New Positions: 0
# Closed Positions: 1
# Increased Positions: 0
# Reduced Positions: 1
# Net Buyers: -1
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.